Triamcinolone Acetonide Cream USP — Class II drug recall D-1497-2022
Terminated recall by Padagis US LLC, reported 2022-09-07, distributed nationwide. CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.
| Recall number | D-1497-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Padagis US LLC, Minneapolis, MN, United States |
| Recall initiated | 2022-08-17 |
| Classified | 2022-09-07 |
| Reported by FDA | 2022-09-07 |
| Terminated | 2023-09-28 |
| Distributed | Nationwide (US) |
| Quantity | 57,816 tubes |
| Reason classes | cgmp |
| NDC | 45802-0063, 45802-0063-05, 45802-0063-35, 45802-0063-36, 45802-0064, 45802-0064-05, 45802-0064-35, 45802-0064-36, 45802-0065, 45802-0065-35 |
| Lot numbers | 2CT0486 |
| Expiration dates | 2024-02-29 |
Product
Triamcinolone Acetonide Cream USP, 0.1%, 80 g tube, Rx Only, Manufactured By Perrigo, Bronx, NY 10457, Distributed By Perrigo, Allegan, MI 49010, NDC 45802-064-36.
Reason for recall
CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1497-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.